Donor surfactant protein D (SP-D) polymorphisms are associated with lung transplant outcome

American Journal of Transplantation

Volumn 13, Issue 8, 2013, Pages 2130-2136

  Aramini, B ^a   Kim, C ^a   Diangelo, S ^b   Petersen, E ^a   Lederer, D J ^a   Shah, L ^a   Robbins, H ^a   Floros, J ^b   Arcasoy, S M ^a   Sonett, J R ^a   D'Ovidio, F ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Lung allograft immunity; lung transplantation; polymorphisms; pulmonary surfactant proteins

Indexed keywords

ALANINE 160 ALANINE; ALANINE 160 THREONINE; AMINO ACID; DNA; METHIONINE 11 METHIONINE; METHIONINE 11 THREONINE; SURFACTANT PROTEIN D; THREONINE 11 THREONINE; THREONINE 160 THREONINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUSE OF DEATH; CHRONIC LUNG ALLOGRAFT DYSFUNCTION; CODON; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENOTYPE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HOMOZYGOTE; HUMAN; HYPOTHESIS; INNATE IMMUNITY; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PYROSEQUENCING; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL;

LUNG ALLOGRAFT IMMUNITY; LUNG TRANSPLANTATION; POLYMORPHISMS; PULMONARY SURFACTANT PROTEINS;

ADULT; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNITY, INNATE; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84881378308     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12326     Document Type: Article

References (45)

1. Holmskov U, Thiel S, Jensenius JC., Collectins and Ficolins: Humoral lectins of the innate immune defense. Annu Rev Immunol 2003; 21: 547-578.
2. McCormack FX, Whitsett JA., The pulmonary collectins SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002; 109: 707-712.
3. Turner MW., The role of mannose-binding lectin in health and disease. Mol Immunol 2003; 40: 423.
4. Hakansson K, Lim NK, Hoppe HJ, Reid KB., Crystal structure of the trimeric α-helical coiled-coil and the three lectin domains of human lung surfactant protein D. Structure Fold Des 1999; 7: 255.
5. Hartshorn K, Chang D, Rust K, White M, Heuser J, Crouch E., Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A. Am J Physiol 1996; 271: L753.
6. Crouch E, Chang D, Rust K, Persson A, Heuser J., Recombinant pulmonary surfactant protein D: Post-translational modification and molecular assembly. J Biol Chem 1994; 269: 15808.
7. Palaniyar N, Zhang L, Kuzmenko A, et al. The role of pulmonary collectin N-terminal domains in surfactant structure, function, and homeostasis in vivo. J Biol Chem 2002; 277: 26971.
8. Crouch E, Hartshorn K, Ofek I., Collectins and pulmonary innate immunity. Immunol Rev 2000; 173: 52-565.
9. McCormack FX, Gibbons R, Ward SR, Kuzmenko A, Wu H, Deepe GS Jr., Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 2003; 278: 36250.
10. Wu H, Kuzmenko A, Wan S, et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 2003; 111: 1589.
11. Phelps DS., Surfactant regulation of host defense function in the lung: A question of balance. Pediatric Path Mol Med 2001; 20: 269-292.
12. Gardai SJ, Xiao YQ, Dickinson M, et al. By binding SIRP or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003; 115: 13-23.
13. Sano H, Chiba H, Iwaki D, Sohma H, Voelker DR, Kuroki Y., Surfactant proteins A and D bind CD14 by different mechanisms. J Biol Chem 2000; 5: 22442-22451.
14. Vandivier RW, Ogden CA, Fadok VA, et al. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: Calreticulin and CD91 as a common collectin receptor complex. J Immunol 2002; 169: 3978-3986.
15. Gardai SJ, Xiao XY, Dickinson M, et al. By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003; 115: 13-23.
16. LeVine AM, Whitsett JA, Gwozdz JA, et al. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 2000; 165: 3934.
17. Wert SE, Yoshida M, LeVine AM, et al. Increased metallo-proteinase activity, oxidant production, and emphysema in surfactant protein D gene inactivated mice. Proc Natl Acad Sci USA 2000; 97: 5972.
18. Lahti M, Lofgren J, Marttila R, et al. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res 2002; 51: 696-699.
19. Leth-Larsen R, Garred P, Jensenius H, et al. A common polymorphism in the SFTPD gene influences assembly, function and concentration of surfactant protein D. J Immunol 2005; 174: 1532-1538.
20. Pavlovic J, Papagaroufalis C, Xanthou M, et al. Genetic variants of surfactant proteins A, B, C, and D in bronchopulmonary dysplasia. Disease Markers 2006; 22: 277-299.
21. Foreman MG, Kong X, DeMeo DL, et al. Polymorphisms in surfactant protein D are associated with chronic obstructive pulmonary disease. Am J Respis Cell Mol Biol 2011; 44: 316-322.
22. Floros J, Lin HM, Garcia M, et al. Surfactant protein genetic marker alleles identify a subgrioup of tubercolosis in a Mexican population. J Infect Dis 2000; 182: 1473-1478.
23. Guo X, Lin HM, Lin Z, et al. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur Respir J 2001; 18: 482-490.
24. Lin Z, Pearson C, Chinchilli V, et al. Polymorphism of human SP-A, SP-B, and SP-D genes: Association of SP-B Thr131Ile with ARDS. Clin Genet 2000; 58: 181-191.
25. Woodrow JP, Shlobin OA, Barnett SD, Burton N, Natha SD., Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation. J Heart Lung Transplant 2010; 29: 1159-1164.
26. DiAngelo S, Lin Z, Philips S, Ramet M, Floros J., Novel non radioactive, simple and multiplex PCR-cRLP methods for genotyping human SP-A and SP-D gene alleles. Dis Markers 1999; 15: 269-281.
27. Floros J, Hoover RR., Genetics of the hydrophilic surfactant proteins A and D. Biochim Biophys Acta 1998; 1408: 312-322.
28. Fine JP, Gray RJ., A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
29. Zhang X, Akcin H., A SAS macro for direct adjusted survival curves based on Aalen's additive model Comput Methods Programs Biomed 2012; 108: 310-317.
30. Trulock EP, Edwards LB, Taylor DO, et al. Registry of the international society for heart and lung transplantation: Twenty second official adult lung and heart-lung transplant report-2005. J Heart Lung Transplant 2005; 24: 956-967.
31. Boehler A, Kesten S, Weder W, Speich R., Bronchiolitis obliterans after lung transplantation: A review. Chest 1998; 114: 1411-1426.
32. Valentine VG, Robbins RC, Berry GJ, et al. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 1996; 15: 371-383.
33. Ghanekar A, Grant D., Small bowel transplantation. Curr Opin Critic Care. 2001; 7: 133-137.
34. Brown RS, Rush SH, Rosen HR, et al. Liver and intestine transplantation. Am J Transplant 2004; 4 (S9): 81-92.
35. Wynn JJ, Distant DA, Pirsch JD, et al. Kidney and pancreas transplantation. Am J Transplant 2004; 4 (S9): 72-80.
36. Pierson RN, Barr ML, McCullough KP, et al. Thoracic organ transplantation. Am J Transplant 2004; 4 (S9): 93-105.
37. Davis RD Jr., Lau CL, Eubanks S, et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003; 125 (3 Pt 1): 533-542.
38. D'Ovidio F, Mura M, Tsang M, et al. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J Thorac Cardiovasc Surg 2005; 129: 1144-1152.
39. Hills BA., Surface active phospholipids: A Pandora's box of clinical applications. Part II. Barrier and lubricating properties. Internal Med J 2002; 32: 242-251.
40. Goerke J., Pulmonary surfactant: Functions and molecular composition. Biochim Biophys Acta 1998; 1408: 79-89.
41. Haagsman HP, Diemel RV., Sufactant associated proteins: Functions and structural variation. Comp Biochem Physiol A 2001; 129: 91-108.
42. Heidinger K, Konig IR, Bohnert A, et al. Polymorphisms in the human surfactant protein-D (SFTPD) gene: Strong evidence that serum levels of surfactant protein-D (SP-D) are genetically influenced. Immunogenetics 2005; 57: 1-7.
43. Silveyra P, Floros J., Genetic variant associations of human SP-A and SP-D with acute and chronic lung injury. Front Biosci 2012; 17: 407-409.
44. Sorensen GL, Hjelmborg JB, Kyvik KO, et al. Genetic and environmental influences of surfactant protein D serum levels. Am J Physiol Lung Cell Mol Physiol 2006; 290; L1010-L1017.
45. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.